Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation
From MaRDI portal
Publication:2864029
DOI10.2202/1544-6115.1435zbMATH Open1276.92037OpenAlexW1965276679WikidataQ33397034 ScholiaQ33397034MaRDI QIDQ2864029FDOQ2864029
Authors: David J. Hand 
Publication date: 5 December 2013
Published in: Statistical Applications in Genetics and Molecular Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2202/1544-6115.1435
Recommendations
- A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
- Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest
- Organizing a competition on clinical mass spectrometry based proteomic diagnosis
- Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples
- Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach
Cited In (13)
- International Competition on Mass Spectrometry Proteomic Diagnosis
- On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction
- Finding causative genes from high-dimensional data: an appraisal of statistical and machine learning approaches
- Breast cancer prediction using the isotonic separation technique
- A classification model for the Leiden proteomics competition
- Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach
- Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest
- Gradient boosting for high-dimensional prediction of rare events
- Organizing a competition on clinical mass spectrometry based proteomic diagnosis
- A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
- Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples
- Prototype based fuzzy classification in clinical proteomics
- Detection of cancer-specific markers amid massive mass spectral data
This page was built for publication: Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2864029)
